Biotech Values

[miljenko]

The companies currently expect to manufacture globally up to 100 million doses by the end of 2020 and potentially more than 1.3 billion doses by the end of 2021, subject to final dose selection from their clinical trial.

All this is starting to be more than ridiculous.

They do not know what vaccine candidate will move forward, they do not know will there be any protective effects, but WHEN GOV pays the bills, lets do spending!